A vaccine against Bovine Leukemia Virus
Datum: 5.2.2014
Technology request: A vaccine against Bovine Leukemia Virus
Reference: TOBE20131206001
Summary: A Belgian university team developed a recombinant Bovine Leukemia Virus (BLV) with attenuated phenotype and two specific mutations. Efficacy, persistence, safety and pathogenicity make this vaccine unique. The research team is looking for collaboration with companies interested in license agreement.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
